169 related articles for article (PubMed ID: 19464159)
1. Defining chronic obstructive pulmonary disease in older persons.
Vaz Fragoso CA; Concato J; McAvay G; Van Ness PH; Rochester CL; Yaggi HK; Gill TM
Respir Med; 2009 Oct; 103(10):1468-76. PubMed ID: 19464159
[TBL] [Abstract][Full Text] [Related]
2. Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions.
Vaz Fragoso CA; Concato J; McAvay G; Van Ness PH; Rochester CL; Yaggi HK; Gill TM
Respir Med; 2010 Aug; 104(8):1189-96. PubMed ID: 20199857
[TBL] [Abstract][Full Text] [Related]
3. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.
Vaz Fragoso CA; Concato J; McAvay G; Van Ness PH; Rochester CL; Yaggi HK; Gill TM
Am J Respir Crit Care Med; 2010 Mar; 181(5):446-51. PubMed ID: 20019341
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the fixed ratio and the
Oh DK; Baek S; Lee SW; Lee JS; Lee SD; Oh YM
Int J Chron Obstruct Pulmon Dis; 2018; 13():903-915. PubMed ID: 29559774
[TBL] [Abstract][Full Text] [Related]
5. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
6. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
Holt NR; Thompson BR; Miller B; Borg BM
Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
[TBL] [Abstract][Full Text] [Related]
7. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study.
Runarsdottir SB; Gudmundsson G; Aspelund T; Harris TB; Launer LJ; Gudnason V; Gislason T
COPD; 2013 Aug; 10(4):493-9. PubMed ID: 23875743
[TBL] [Abstract][Full Text] [Related]
9. Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.
Odeyemi YE; Lewis O; Ngwa J; Dodd K; Gillum RF; Mehari A
J Natl Med Assoc; 2019 Feb; 111(1):94-100. PubMed ID: 30064691
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.
Huprikar NA; Skabelund AJ; Bedsole VG; Sjulin TJ; Karandikar AV; Aden JK; Morris MJ
Respir Care; 2019 Jul; 64(7):786-792. PubMed ID: 30890630
[TBL] [Abstract][Full Text] [Related]
11. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
Tan DJ; Lodge CJ; Walters EH; Bui DS; Pham J; Lowe AJ; Bowatte G; Vicendese D; Erbas B; Johns DP; James AL; Frith P; Hamilton GS; Thomas PS; Wood-Baker R; Han MK; Washko GR; Abramson MJ; Perret JL; Dharmage SC
Am J Respir Crit Care Med; 2024 Jun; 209(12):1431-1440. PubMed ID: 38236192
[No Abstract] [Full Text] [Related]
12. The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study.
Voraphani N; Stern DA; Zhai J; Wright AL; Halonen M; Sherrill DL; Hallberg J; Kull I; Bergström A; Murray CS; Lowe L; Custovic A; Morgan WJ; Martinez FD; Melén E; Simpson A; Guerra S
Lancet Respir Med; 2022 Jan; 10(1):59-71. PubMed ID: 34843665
[TBL] [Abstract][Full Text] [Related]
13. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
[TBL] [Abstract][Full Text] [Related]
15. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.
Hansen JE; Sun XG; Wasserman K
Chest; 2007 Feb; 131(2):349-55. PubMed ID: 17296632
[TBL] [Abstract][Full Text] [Related]
16. Fixed ratio or lower limit of normal for the FEV
Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
[TBL] [Abstract][Full Text] [Related]
17. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
[TBL] [Abstract][Full Text] [Related]
18. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
19. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Global Lung Initiative 2012 with Third National Health and Nutrition Examination Survey Spirometry Reference Values. Implications in Defining Obstruction.
Huprikar NA; Holley AB; Skabelund AJ; Hayes JA; Hiles PD; Aden JK; Morris MJ; Hersh AM
Ann Am Thorac Soc; 2019 Feb; 16(2):225-230. PubMed ID: 30427734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]